CL2009000985A1 - Composicion oftalmica que comprende entre 0,16 y 0,19% p/v de un galactomanano, alrededor de 0,7% p/v de un borato, cis-diol y menos de 5 ppm de concentracion de cationes divalentes; y su uso para lubricar el ojo. - Google Patents
Composicion oftalmica que comprende entre 0,16 y 0,19% p/v de un galactomanano, alrededor de 0,7% p/v de un borato, cis-diol y menos de 5 ppm de concentracion de cationes divalentes; y su uso para lubricar el ojo.Info
- Publication number
- CL2009000985A1 CL2009000985A1 CL2009000985A CL2009000985A CL2009000985A1 CL 2009000985 A1 CL2009000985 A1 CL 2009000985A1 CL 2009000985 A CL2009000985 A CL 2009000985A CL 2009000985 A CL2009000985 A CL 2009000985A CL 2009000985 A1 CL2009000985 A1 CL 2009000985A1
- Authority
- CL
- Chile
- Prior art keywords
- galactomannan
- borate
- diol
- cis
- lubricate
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 title abstract 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 title abstract 2
- 229920000926 Galactomannan Polymers 0.000 title abstract 2
- 150000001768 cations Chemical class 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000607 artificial tear Substances 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 239000003974 emollient agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4817508P | 2008-04-26 | 2008-04-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2009000985A1 true CL2009000985A1 (es) | 2010-01-15 |
Family
ID=40886688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2009000985A CL2009000985A1 (es) | 2008-04-26 | 2009-04-24 | Composicion oftalmica que comprende entre 0,16 y 0,19% p/v de un galactomanano, alrededor de 0,7% p/v de un borato, cis-diol y menos de 5 ppm de concentracion de cationes divalentes; y su uso para lubricar el ojo. |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US20090270345A1 (enExample) |
| EP (1) | EP2278954B1 (enExample) |
| JP (1) | JP5659149B2 (enExample) |
| KR (1) | KR101592872B1 (enExample) |
| CN (1) | CN102046150B (enExample) |
| AR (2) | AR071834A1 (enExample) |
| AU (1) | AU2009240488B2 (enExample) |
| BR (1) | BRPI0910717A2 (enExample) |
| CA (1) | CA2722508C (enExample) |
| CL (1) | CL2009000985A1 (enExample) |
| ES (1) | ES2818619T3 (enExample) |
| MX (1) | MX2010011736A (enExample) |
| NZ (1) | NZ589323A (enExample) |
| TW (1) | TWI526213B (enExample) |
| UY (1) | UY31785A1 (enExample) |
| WO (1) | WO2009132294A1 (enExample) |
| ZA (1) | ZA201007644B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7220431B2 (en) * | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
| US20050137166A1 (en) * | 2003-12-19 | 2005-06-23 | Alcon, Inc. | Use of cooling agents to relieve mild ocular irritation and enhance comfort |
| AR071834A1 (es) * | 2008-04-26 | 2010-07-21 | Alcon Res Ltd | Sistema polimerico de lagrimas artificiales |
| TWI547522B (zh) | 2009-07-07 | 2016-09-01 | 愛爾康研究有限公司 | 環氧乙烷環氧丁烷嵌段共聚物組成物 |
| TWI478730B (zh) * | 2009-12-03 | 2015-04-01 | Alcon Res Ltd | 眼科乳劑 |
| HUE038821T2 (hu) * | 2009-12-03 | 2018-11-28 | Novartis Ag | Karboxivinil polimert tartalmazó nanorészecske szuszpenziók |
| NZ603345A (en) * | 2010-05-05 | 2014-12-24 | Alcon Res Ltd | Stabilized ophthalmic galactomannan formulations |
| UA113434C2 (uk) * | 2012-05-04 | 2017-01-25 | Алкон Рісерч, Лтд. | Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням |
| US20130344619A1 (en) | 2012-06-21 | 2013-12-26 | Lightship Medical Limited | Glucose sensor |
| US11730699B2 (en) | 2018-02-21 | 2023-08-22 | Alcon Inc. | Lipid-based ophthalmic emulsion |
| TWI913170B (zh) | 2018-02-21 | 2026-01-21 | 瑞士商愛爾康公司 | 基於脂質的眼用乳劑 |
| JP6705495B1 (ja) * | 2018-12-26 | 2020-06-03 | 株式会社Ｊｖｃケンウッド | 車両用記録制御装置、車両用記録装置、車両用記録制御方法およびプログラム |
| US12329763B2 (en) * | 2019-03-04 | 2025-06-17 | Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. | Composition of lanosterol prodrug compound, preparation method therefor and use thereof |
| TWI757773B (zh) * | 2019-06-28 | 2022-03-11 | 瑞士商愛爾康公司 | 眼用組成物 |
| BR112022002467A2 (pt) | 2019-09-18 | 2022-07-19 | Alcon Inc | Insertos oculares de hidrogel suave embalados a úmido |
| CN114191378A (zh) * | 2021-11-23 | 2022-03-18 | 温州医科大学附属眼视光医院 | 一种地夸磷索缓释凝胶及其制备方法与应用 |
| AU2025233965A1 (en) | 2024-03-04 | 2026-07-16 | Alcon Inc. | Carbamoylphenylboronic acid-containing acrylic monomers and uses thereof |
| KR20260082012A (ko) | 2024-11-27 | 2026-06-04 | 허종욱 | 인공눈물의 효과 영향 및 안구 안정성 비교 연구 방법 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4136173A (en) * | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Mixed xanthan gum and locust beam gum therapeutic compositions |
| GB1593954A (en) * | 1977-01-31 | 1981-07-22 | American Home Prod | Xanthan gum or locust bean gum topical therapeutic compositions |
| US5505953A (en) * | 1992-05-06 | 1996-04-09 | Alcon Laboratories, Inc. | Use of borate-polyol complexes in ophthalmic compositions |
| DK0999854T3 (da) * | 1997-07-29 | 2004-02-09 | Alcon Mfg Ltd | Omskiftelige viskoelastiske systemer, der indeholder galactomannanpolymerer og -borater |
| DE69818675T2 (de) * | 1997-07-29 | 2004-07-29 | Alcon Laboratories, Inc., Fort Worth | Galaktomannanpolymere und borat enthaltende augenarzneimittel |
| IT1298758B1 (it) * | 1998-03-19 | 2000-02-02 | Angelini Ricerche Spa | Soluzione umettante e lubrificante per uso oftalmico |
| TWI336257B (en) * | 2003-06-13 | 2011-01-21 | Alcon Inc | Ophthalmic compositions containing a synergistic combination of three polymers |
| WO2005060933A1 (en) * | 2003-12-11 | 2005-07-07 | Alcon, Inc. | Ophthalmic compositions containing a polysaccharide/borate gelling system |
| DE102006031500A1 (de) | 2006-07-06 | 2008-04-17 | Henkel Kgaa | O/W-Emulsion |
| WO2008036855A2 (en) * | 2006-09-21 | 2008-03-27 | Alcon Research, Ltd. | Self-preserved aqueous pharmaceutical compositions |
| US8119112B2 (en) * | 2008-01-31 | 2012-02-21 | Bausch & Lomb Incorporated | Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid |
| US9096819B2 (en) * | 2008-01-31 | 2015-08-04 | Bausch & Lomb Incorporated | Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer |
| AR071834A1 (es) * | 2008-04-26 | 2010-07-21 | Alcon Res Ltd | Sistema polimerico de lagrimas artificiales |
| NZ603345A (en) * | 2010-05-05 | 2014-12-24 | Alcon Res Ltd | Stabilized ophthalmic galactomannan formulations |
-
2009
- 2009-04-24 AR ARP090101464A patent/AR071834A1/es not_active Application Discontinuation
- 2009-04-24 KR KR1020107026488A patent/KR101592872B1/ko active Active
- 2009-04-24 ES ES09734932T patent/ES2818619T3/es active Active
- 2009-04-24 AU AU2009240488A patent/AU2009240488B2/en active Active
- 2009-04-24 EP EP09734932.8A patent/EP2278954B1/en active Active
- 2009-04-24 WO PCT/US2009/041699 patent/WO2009132294A1/en not_active Ceased
- 2009-04-24 CA CA2722508A patent/CA2722508C/en active Active
- 2009-04-24 UY UY31785A patent/UY31785A1/es not_active Application Discontinuation
- 2009-04-24 BR BRPI0910717A patent/BRPI0910717A2/pt not_active Application Discontinuation
- 2009-04-24 JP JP2011506485A patent/JP5659149B2/ja active Active
- 2009-04-24 CN CN2009801189624A patent/CN102046150B/zh active Active
- 2009-04-24 TW TW098113635A patent/TWI526213B/zh active
- 2009-04-24 CL CL2009000985A patent/CL2009000985A1/es unknown
- 2009-04-24 US US12/429,942 patent/US20090270345A1/en not_active Abandoned
- 2009-04-24 MX MX2010011736A patent/MX2010011736A/es active IP Right Grant
- 2009-04-24 NZ NZ589323A patent/NZ589323A/en not_active IP Right Cessation
-
2010
- 2010-10-26 ZA ZA2010/07644A patent/ZA201007644B/en unknown
-
2011
- 2011-11-22 US US13/302,439 patent/US8685945B2/en active Active
-
2014
- 2014-02-14 US US14/180,396 patent/US9259472B2/en active Active
-
2018
- 2018-07-26 AR ARP180102103 patent/AR112286A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TWI526213B (zh) | 2016-03-21 |
| CA2722508C (en) | 2016-08-16 |
| US9259472B2 (en) | 2016-02-16 |
| EP2278954B1 (en) | 2020-08-26 |
| CN102046150A (zh) | 2011-05-04 |
| BRPI0910717A2 (pt) | 2015-09-29 |
| ES2818619T3 (es) | 2021-04-13 |
| EP2278954A1 (en) | 2011-02-02 |
| US8685945B2 (en) | 2014-04-01 |
| NZ589323A (en) | 2012-04-27 |
| CN102046150B (zh) | 2013-07-24 |
| AR112286A2 (es) | 2019-10-09 |
| JP5659149B2 (ja) | 2015-01-28 |
| ZA201007644B (en) | 2011-12-28 |
| US20120070402A1 (en) | 2012-03-22 |
| MX2010011736A (es) | 2011-01-21 |
| AU2009240488A1 (en) | 2009-10-29 |
| US20090270345A1 (en) | 2009-10-29 |
| KR20110007228A (ko) | 2011-01-21 |
| UY31785A1 (es) | 2009-08-03 |
| CA2722508A1 (en) | 2009-10-29 |
| TW200948367A (en) | 2009-12-01 |
| KR101592872B1 (ko) | 2016-02-12 |
| US20140161760A1 (en) | 2014-06-12 |
| AR071834A1 (es) | 2010-07-21 |
| AU2009240488B2 (en) | 2013-02-21 |
| JP2011518842A (ja) | 2011-06-30 |
| WO2009132294A1 (en) | 2009-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR112286A2 (es) | Sistema polimérico de lágrimas artificiales | |
| CL2020000468A1 (es) | Uso de una formulación estable que comprende una enzima de reemplazo para la enzima lisosomal (divisional solicitud 201801220) | |
| ES2530723T3 (es) | Reposición y enriquecimiento terapéuticos de la lubricación de la superficie ocular | |
| CL2011000901A1 (es) | Compuestos nitrogenados; composicion farmaceutica que comprende a dichos compuestos; su uso para la modulacion del flujo de cromoforos en un ciclo retinoide para tratar la degeneracion macular asociada con la edad, la distrofia macular de stargardt, desprendimiento de retina, retinopatia hemorragica, retinitis pigmentosa, neuropatia optica,uveitis. | |
| CL2008001620A1 (es) | Induccion de fenotipo tolerogenico en celulas dendriticas maduras | |
| CL2009001340A1 (es) | Compuesto de insulina lispro pegilada o una sal del mismo que comprende una cadena a de sec no:1, una cadena b de sec no:3 y el peg es de un peso entre 20 a 40 kda; uso de dicho compuesto para tratar hipoglicemia o diabetes; composición farmacéutica que comprende dicho compuesto; y proceso para elaborar dicho compuesto. | |
| MX373050B (es) | Antagonistas de activina-actrii y usos para incrementar los niveles de globulos rojos. | |
| CR8858A (es) | Derivados de sulfamato y sulfamida para el tratamiento de epilepsia y trastornos relacionados | |
| CR9114A (es) | 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion | |
| AR059456A1 (es) | Agente benefico que comprende particulas de suministro | |
| CO6440528A2 (es) | Composiciones adyuvantes que comprenden un agente de isotonicidad no iónico. | |
| CL2008000893A1 (es) | Composición para el cuidado bucal que comprende una cantidad efectiva de un aminoácido básico y un agente antibacteriano; uso en el tratamiento antibacteriano de la cavidad bucal. | |
| ATE544444T1 (de) | Zusammensetzungen für die nasale abgabe | |
| CO6311008A2 (es) | Composicion farmaceutica que comprende un agente que activa las celulas t regulatorias cd4+cd25+ | |
| CY1114712T1 (el) | Υδατικες φαρμακευτικες συνθεσεις περιεχουσες συμπλοκα βορικου-πολυολης | |
| CR11418A (es) | Trans-clomifeno para el sindrome metabolico | |
| AR089269A1 (es) | Composiciones para el cuidado oral | |
| MX2010000266A (es) | Un método para disminuir los síntomas del consumo de alcohol. | |
| AR063026A1 (es) | Anticuerpos dirigidos contra ccr5 y la utilizacion de los mismos | |
| UY29248A1 (es) | Indoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización | |
| ECSP099386A (es) | Agentes para combatir parásitos en animales | |
| ECSP12012033A (es) | Triple combinación para bajar la presión intraocular | |
| AR072799A1 (es) | Composicion para la higiene personal | |
| PE20121537A1 (es) | Combinacion de teobromina con un descongestivo | |
| CL2009000986A1 (es) | Uso de inhibidores de pai-1 para la p0reparacion de un medicamento util en el tratamiento de hipertension ocular y glaucoma |